Target intelligence / Profile preview

Transmembrane protein 230 pseudogene

Molecular classification
Other (Pseudogene)
01

Overview

The Transmembrane protein 230 pseudogene (ENSG00000271385) is a nonfunctional, noncoding genomic sequence highly similar to the protein-coding TMEM230 gene. Pseudogenes typically contain mutations or disruptions that preclude expression of a functional protein. While some pseudogenes can exert regulatory effects on gene expression, most are not direct therapeutic targets and do not produce proteins. This entry should not be confused with the functional TMEM230 gene, which encodes a neuronal vesicle trafficking protein involved in Parkinson's disease and cancer[1][2][4][6].

02

Biological functions

Other (Pseudogenes, in general, may participate in gene regulation or serve as molecular fossils, but no specific biological function is assigned to this pseudogene[1])
03

Disease associations

Other (No direct, validated disease association for this pseudogene; TMEM230 [the protein-coding gene] has links to neurodegeneration and cancer[2][4][6], but this entry does not)

Beyond the preview

Go deeper on Transmembrane protein 230 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane protein 230 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call